From R&D investment considerations to product launch optimization, our experts in science and business help biotech companies prioritize their objectives for success. Watch to learn more. Related Practice Life Sciences & Pharma 03162023170305
Case Study Life Sciences & Pharma Cost and Reimbursement Assessment for a Biopharmaceutical Company May 7, 2024 A large biopharmaceutical company developing chimeric antigen receptor T-cell (CAR-T) therapies
Case Study Biotech and Pharmaceuticals Reimbursement Assessment for a Therapy for Hemodialysis Patients May 3, 2024 A biopharmaceutical company with a novel treatment of chronic kidney disease-associated pruritus asked L.E.K. to assess the potential risk of bundling of…
Published Articles Marketing & Sales How Can Businesses Survive the ‘Cookie Apocalypse’? April 25, 2024
Published Articles Biotech and Pharmaceuticals EU Pharmaceutical Legislation Revisions: What Are the Implications for Biopharma? December 20, 2023
Executive Insights Life Sciences & Pharma Initial Drugs Selected for Medicare Price Negotiation: Emerging Perspectives September 1, 2023